Send feedback

FDFT1 p.Lys45Arg

c.134A>G · rs4731 · VCV1285264

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 5 submitters
AlphaMissense
likely benign
0.0639 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 8.22%, nfe) — too common for a highly-penetrant pathogenic allele
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
squalene synthase deficiency

Computational evidence

Protein change
AlphaMissense0.0639likely benign
REVEL0.082moderately benign-leaning
SaProtLLR -6.80tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 5.9GERP 1.7, phastCons 1
Regional constrainto/e 1.77unconstrained · MANE · 36 kb · p 1.6e-69 · regional, not allelic
Overall
CADD19.24PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.22% European (non-Finnish) · 97,034/1,179,820 alleles
Filtering AF 8.18% ClinGen BA1/BS1 input FAF95, joint · FAF99 8.16%
Overall 7.57% 122,178/1,613,782 alleles · common exomes 112,772/1,461,528 · genomes 9,406/152,254 · joint denominator
Ancestry group Frequency 1 in
Amishnot grpmax-eligible 17.1% 6
Ashkenazi Jewishnot grpmax-eligible 16.1% 6
Finnishnot grpmax-eligible 8.8% 11
European (non-Finnish)grpmax 8.22% 12
Remaining individualsnot grpmax-eligible 7.7% 13
Middle Eastern 7.37% 14
South Asian 5.86% 17
Admixed American 3.52% 28
African / African-American 1.84% 54
East Asian 1.14% 88

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
FDFT1
Protein
p.Lys45Arg
Coding
c.134A>G
MANE Select
NM_004462
dbSNP
rs4731
Type
single nucleotide variant
Location
chr8:11808828 (GRCh38)
Gene constraint
LOEUF 1.764 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 89.14 · 32 PDB
Residue 45
a UniProt-annotated variant site (influences plasma cholesterol levels; associated with increased total cholesterol and non-high-density lipoprotein cholesterol); an α-helix
Full FDFT1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/fdft1-p-lys45arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown